​

Aura Biosciences Ownership | Who Owns Aura Biosciences?

OverviewForecastFinancialsChart

Aura Biosciences Ownership Summary

Aura Biosciences is owned by 79.43% institutional investors, 3.09% insiders, and 17.47% retail investors. Matrix capital management company, lp is the largest institutional shareholder, holding 13.94% of AURA shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 8.16% of its assets in Aura Biosciences shares.

AURA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAura Biosciences79.43%3.09%17.47%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Matrix capital management company, lp6.92M13.94%$56.91M
Adage capital partners gp4.88M9.83%$40.12M
Eventide asset management4.08M8.22%$33.54M
Blackrock funding, inc. /de3.55M7.15%$29.19M
Medicxi ventures management (jersey)3.04M6.12%$24.99M
Blackrock3.01M6.08%$22.72M
Long focus capital management2.54M5.11%$20.86M
Vanguard group1.92M3.86%$15.76M
Franklin resources1.72M3.47%$14.16M
Nantahala capital management1.27M2.56%$10.44M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Medicxi ventures management (jersey)3.04M4.72%$24.99M
Regency capital management inc.\de609.42K2.71%$5.01M
Matrix capital management company, lp6.92M2.65%$56.91M
Levin capital strategies1.25M0.97%$10.26M
Decheng capital515.55K0.91%$4.24M
Long focus capital management2.54M0.68%$20.86M
Eventide asset management4.08M0.61%$33.54M
Nantahala capital management1.27M0.45%$10.44M
Tbh global asset management60.32K0.12%$495.85K
Ubs oconnor136.52K0.09%$1.12M

Top Buyers

HolderShares% AssetsChange
Long focus capital management2.54M0.68%1.40M
Levin capital strategies1.25M0.97%833.98K
Ubs group687.32K0.00%665.34K
Blackrock3.01M0.00%560.52K
Blackrock funding, inc. /de3.55M0.00%391.04K

Top Sellers

HolderShares% AssetsChange
Eventide asset management4.08M0.61%-1.72M
Jefferies financial group---222.50K
Verition fund management---151.68K
Adar1 capital management---73.66K
Fmr31.55K--69.67K

New Positions

HolderShares% AssetsChangeValue
Susquehanna group, llp27.34K-27.34K$224.74K
Creative planning21.41K0.00%21.41K$176.03K
Intech investment management20.93K0.00%20.93K$172.01K
Gsa capital partners llp18.28K0.01%18.28K$150.00K
Quest partners16.51K0.02%16.51K$135.72K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-4.00
Capital performance advisors llp-25.00
Group one trading-189.00
Metropolitan life insurance co/ny-1.55K
Entrypoint capital-3.57K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20249611.63%39,448,5527.00%791.44%5735.71%17-29.17%
Sep 30, 20248613.16%36,866,668-6.95%741.16%41-8.89%2525.00%
Jun 30, 202476-3.80%39,620,9981.29%800.82%45-2.17%2011.11%
Mar 31, 2024798.22%39,115,3235.72%981.05%46-9.80%1863.64%
Dec 31, 20237312.31%36,998,81234.61%961.84%5159.38%11-42.11%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Eventide Healthcare & Life Sciences I4.08M8.16%-1.72M
iShares Russell 2000 ETF1.22M2.43%-10.56K
Franklin Biotechnology Discv A(acc)USD1.10M2.21%-
Vanguard Total Stock Mkt Idx Inv1.02M2.04%-
Franklin Biotechnology Discovery A619.99K1.24%-
Vanguard Institutional Extnd Mkt Idx Tr569.63K1.14%1.78K
Fidelity Small Cap Index461.53K0.92%-8.64K
iShares Russell 2000 Value ETF433.91K0.86%-
T. Rowe Price Health Sciences354.89K0.71%-
iShares Biotechnology ETF283.93K0.57%-3.16K

Recent Insider Transactions

DateNameRoleActivityValue
Apr 16, 2025Elazzouzi Amy Senior Vice President, FinanceSell$4.92K
Apr 16, 2025Kilroy Conor See RemarksSell$39.32K
Feb 18, 2025Plavsic Mark Chief Technology OfficerSell$16.67K
Feb 18, 2025Elazzouzi Amy Senior Vice President, FinanceSell$10.88K
Feb 18, 2025Hopkins Janet Jill Chief Medical OfficerSell$19.64K

Insider Transactions Trends

DateBuySell
2025 Q1-6
2024 Q4-6
2024 Q3--
2024 Q2--
2024 Q1-2

AURA Ownership FAQ

Who Owns Aura Biosciences?

Aura Biosciences shareholders are primarily institutional investors at 79.43%, followed by 3.09% insiders and 17.48% retail investors. The average institutional ownership in Aura Biosciences's industry, Biotech Stocks , is 68.48%, which Aura Biosciences exceeds.

Who owns the most shares of Aura Biosciences?

Aura Biosciences’s largest shareholders are Matrix capital management company, lp (6.92M shares, 13.94%), Adage capital partners gp (4.88M shares, 9.83%), and Eventide asset management (4.08M shares, 8.22%). Together, they hold 31.98% of Aura Biosciences’s total shares outstanding.

Does Blackrock own Aura Biosciences?

Yes, BlackRock owns 6.08% of Aura Biosciences, totaling 3.01M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.72M$. In the last quarter, BlackRock increased its holdings by 560.52K shares, a 22.93% change.

Who is Aura Biosciences’s biggest shareholder by percentage of total assets invested?

Medicxi ventures management (jersey) is Aura Biosciences’s biggest shareholder by percentage of total assets invested, with 4.72% of its assets in 3.04M Aura Biosciences shares, valued at 24.99M$.

Who is the top mutual fund holder of Aura Biosciences shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Aura Biosciences shares, with 8.16% of its total shares outstanding invested in 4.08M Aura Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools